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OBJECTIVES: The incidence of obesity and particularly super obesity, has increased tremendously. At our
institution, super obesity represents 30.1% of all severely obese individuals in the bariatric surgery program. In
super obesity, surgical morbidity is higher and the results are worse compared with morbid obesity,
independent of the surgical technique. The primary strategy for minimizing complications in these patients is to
decrease the body mass index before surgery. Preoperative weight reduction can be achieved by a hypocaloric
diet, drug therapy, an intragastric balloon, or hospitalization. The objective of this study was to analyze the
results of a period of hospitalization for preoperative weight loss in a group of super-obese patients.
METHODS: Twenty super-obese patients were submitted to a weight loss program between 2006 and 2010. The
mean patient age was 46 years (range 21-59). The mean BMI was 66 kg/m2 (range 51-98) and 12 were women.
The average hospital stay was 19.9 weeks and the average weight loss was 19% of the initial weight (7-37%).
The average caloric intake was 5 kcal/kg/day. After the weight loss program, the patients underwent gastric
bypass surgery.
RESULTS: The statistical analysis revealed that after 14 weeks of treatment (15% loss of initial weight), the
weight loss was not significant. All patients had satisfactory surgical recovery and were discharged after an
average of 4.6 days.
CONCLUSION: In super obesity, preoperative weight loss is an important method for reducing surgical risks.
Hospitalization and a hypocaloric diet are safe and effective. After 14 weeks, the weight loss rate stabilized,
signaling the time of surgical intervention in our study.
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& INTRODUCTION
The incidence of obesity is growing worldwide (1). In the
last decade, the Brazilian population with morbid obesity
has increased by more than 400% (2). Obesity is now a
pandemic and it is directly related to the Westernization of
lifestyles and the development of obesogenic environments
(3).
Surgical treatment using the various available bariatric
techniques has yielded good results. The Roux-en-Y gastric
bypass (GBP) has become the most commonly performed
weight loss operation. More than 75% of patients under-
going GBP experience good long-term results, with low
morbidity and mortality rates (4,5). The eligibility criteria
for weight loss surgery were established in 1991; however,
there are currently no consensus criteria for the preparation
of patients eligible for surgical treatment (6). With the
increase in these bariatric procedures, it is essential to
standardize the preoperative preparation, especially with
regard to selecting the best time to perform the procedure to
optimize the safety and efficacy of the treatment, especially
in higher risk groups (7).
The population with super obesity (body mass index [BMI]
$50 kg/m2) increased by 500% in the last decade and accounts
for 30 to 50% of the morbidly obese. The increasing demand of
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these patients in bariatric surgery centers is quite clear (8). In
the unit of metabolic and bariatric surgery at our university
hospital, the super obese (SO) represent approximately 40% of
all patients followed in the bariatric surgery program.
This group of obese patients has been under investigation
because of the perception of increased risk of complications
and higher rates of treatment failure associated with
increased BMI (9). Super obesity is related to higher
incidences of comorbidities, major technical difficulties,
increased risks of surgical and anesthetic complications
and higher incidences of peri- and postoperative adversities
(10-16). Weight loss before surgery resulted in decreases in
morbidity associated with being overweight.
In a retrospective analysis of the data from patients
operated on five years prior to the start of the preoperative
weight loss program, we found that the incidence of
complications in SO patients was approximately 4-fold higher
compared with morbidly obese group (BMI,50 kg/m2), and
that 80% of the deaths occurred in super obese (17).
Factors related to increased morbidity and mortality in
morbidly obese patients undergoing surgical treatment include
the following: age, gender, presence of comorbidities, risk
factors for pulmonary embolism (PE) and BMI, mainly BMI
.55 kg/m2, which is the main risk factor for mortality (18-20).
The most common strategies for preoperative weight loss
are a hypocaloric diet, drug treatment, an intragastric
balloon and hospitalization. The implementation of a
household diet has poor outcomes, with low adherence
and high dropout rates (21). The options for drug treatment
of obesity are limited; additionally, such treatment has poor
outcomes and is contraindicated in high-risk patients, such
as those with hypertension and heart disease. Most anti-
obesity medications have been withdrawn from the market
due to their side effects and risks. Today, Brazil is the only
country that still sells sibutramine and in Europe, the only
anti-obesity drug currently in use is orlistat (22). The use of
an intra-gastric balloon is restricted due to the high cost of
the intervention. This treatment also requires close nutri-
tional monitoring, has a recommended duration of six
months and has a non-negligible morbidity rate (23).
Hospitalization for weight loss offers the possibility of
keeping the patient in a controlled environment with a
controlled diet of very low caloric value. A very-low-energy
diet can be safely followed in a hospital environment,
providing a greater probability of achieving effective weight
loss. By having access to an auxiliary hospital, where
patients can be hospitalized for a longer period at lower
cost, this option was chosen for preoperative weight loss in
SO high-risk patients in our bariatric surgery program.
We initiated a protocol for preoperative weight loss in SO
patients consisting of the hospitalization of these patients
for biometric monitoring and controlled nutrition. The aim
of this study was to evaluate, in the period of preoperative
preparation, the effect of the length of hospital stay on the
rate of weight loss in SO patients maintained on a very-low-
energy diet to identify a predictor for the optimal time for
surgical intervention following weight loss. A secondary
objective was to analyze the efficacy of weight loss with
respect to postoperative outcome improvement.
& MATERIALS AND METHODS
We studied 20 high-risk, morbidly obese patients with
BMIs $50 kg/m2 who were consecutively included in the
schedule for bariatric surgery at the Hospital das Clı´nicas,
University of Sa˜o Paulo Medical School, which is a
university hospital that is part of Brazil’s public health
system program and is a major hospital complex in Latin
America. The patients were admitted preoperatively to the
Hospital Auxiliary of Suzano for the purpose of losing
weight before surgery. This was a retrospective study
performed by collecting information from patients’ records.
Table 1 shows the demographics of the study group.
The Hospital Auxiliary of Suzano is a 150-bed country
institution located in the city of Suzano, 32 miles from the
city of Sa˜o Paulo, in southeastern Brazil. All the patients
remained on an inpatient basis throughout the period of
stay and were restricted to the diet administered by the
dietitians. Water was provided ad libidum, except in patients
with certain clinical conditions that require fluid restriction.
Patients who were fit for activity were encouraged to
participate in outdoor and indoor physical activities, which
consisted of walks around the hospital in a flat and wooded
area or jogging in a sports court and handcraft workshops
monitored by occupational therapists.
The daily caloric load during hospitalization was offered
in the form of five balanced meals, which were low in
carbohydrates and prioritized vegetables, fruits and lean
proteins. The caloric content varied from 1,500 to 600 cal/
day, which was calculated based on the patient’s initial
weight and was revised as the weight loss progressed
during the period of hospitalization. All patients were
followed by dietitians and medical staff to avoid ketosis,
dehydration and acute malnutrition. Once a month, the
subjects were referred to our main institution for surgical
staff evaluation, analysis of the treatment progress and
decision-making regarding surgery scheduling.
The assessment during the preoperative examination
consisted of the following parameters: composition of the
caloric load of the diet, physical activity capacity level,
length of stay and evolution of the weight curve (Figure 1),
which involved weekly weight measurements during the
hospitalization. Table 1 presents the comorbidities of the
patients at the beginning of treatment and the results in
terms of percentages of initial weight loss, BMI and absolute
weight after the final pre-operative medical treatment.
During the preoperative period, all patients underwent
upper endoscopy, abdominal sonography, thorax radio-
graphy, echocardiography, spirometry and blood and urine
tests. In cases of clinical suspicion of obstructive sleep apnea
syndrome, polysomnography was also performed.
For the statistical analysis of the results, the nonpara-
metric analysis of variance (ANOVA) test and multiple
comparison tests were applied (24,25).
After the preoperative weight loss, all the patients were
submitted to open Roux-en-Y gastric bypass. The technical
aspects of the surgical technique were standardized and
involved a 15- to 20-cm median longitudinal laparotomy, 5-
cm gastric pouch, 50- to 70-cm biliopancreatic limb, 100- to
120-cm Roux limb and retrocolic-retrogastric manual gas-
troenteroanastomosis. All patients received a gastrostomy
and drainage with a silastic drain. The mesenteric defect
and the Petersen’s space were closed. All patients received
prophylactic antibiotics for 48 hours and low-molecular-
weight heparin until the 21st postoperative day, which was
suspended in cases of bleeding. The oral intake was started
in most cases on postoperative day 1.
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The incidences of early complications were retrospec-
tively analyzed and compared with the results of our series
over the last five years to obtain evidence of a positive
impact on operative morbidity and mortality.
All the subjects submitted to this protocol signed a pre-
informed consent form. All the procedures during the
experiment were performed in accordance with the ethical
standards of our institutional ethics committee on human
experimentation and were previously approved by the
committee. Additionally, all the procedures applied in this
study were in accordance with the Helsinki Declaration of
1975.
& RESULTS
Among the subjects studied, there were 12 females and 8
males, with a mean age of 45.6 years. The youngest patient
was 21 years old and the oldest was 59 years old. The
average initial body weight was 180 kg and the average BMI
at the beginning of the hospitalization was 67 kg/m2 (range
51 to 98 kg/m2). Eighteen patients had arterial hypertension
that was previously diagnosed and for which they were
undergoing treatment, 8 patients had type 2 diabetes
mellitus that was being monitored, 5 patients had dyslipi-
demia and 9 patients had obstructive sleep apnea. One
patient had a diagnosis of congestive heart failure, with
grade III diastolic dysfunction. Another patient had chronic
atrial fibrillation. Only 2 of the 20 patients had no diseases
associated with obesity (Table 1).
The daily caloric load during hospitalization ranged from
600 to 1,500 kcal/24 h, averaging 917 kcal/24 h (5 cal/kg/
24 h). The mean length of stay at the Auxiliary Hospital of
Suzano was 19.8 weeks (range 7 to 45 weeks). The mean
percentage of the initial body weight loss was 19.7% (range
7 to 37%). The average BMI after admission to the surgical
unit was 55 kg/m2 (range 45 to 78 kg/m2). Figure 1 shows
the weight curves of the patients over time.
To maintain the representativeness of the sample, we
chose to perform the statistical analysis only until the 24th
week, as the monitoring was performed in only 80% of the
patients at that time point. We used the nonparametric
ANOVA test for ordinal data to determine whether there
was a change in weight over time. After determining the
time point at which the change in weight over the
hospitalization became non-significant, we applied multiple
Table 1 - Demographics of the study group. Gender, age, initial weight and BMI, comorbidities, weight loss percentage
and weight and BMI at the end of the preoperative treatment period (CAF: chronic atrial fibrillation; DLP: dyslipidemia;
DM2: diabetes mellitus type 2; HPB: high blood pressure; OCPD: obsessive-compulsive personality disorder; OSAS:
obstructive sleep apnea syndrome).
Gender Age (years)
Initial body
weight (kg) Initial BMI (kg/m2) Comorbidities
% Loss of initial
body weight
Final weight
(kg) Final BMI (kg/m2)
1 FEM 46 136 59 OSAS HBP knee arthrosis 20 108.8 56
2 MALE 54 207 70 HBP 27.7 149.6 48
3 MALE 24 213.4 78 HBP DM2 20.6 169.4 60
4 MALE 43 269 98 HBP DM2 congestive
heart failure
53.5 124.9 54
5 MALE 46 191 68 HBP DLP OSAS arthrosis 20.5 151.9 54
6 FEM 48 208.7 85 HBP DM2 OSAS 14.1 179.3 73
7 FEM 45 152.2 70 HBP OCPD arthrosis 30.2 106.1 48
8 FEM 46 130 55 HBP DM2 DLP 15.4 110 47
9 FEM 47 170 62 HBP DLP poliomyelitis
sequelae
37 107 39
10 MALE 47 220 78 HBP OSAS CAF 28.6 157 57
11 FEM 53 168.8 51 HBP DM2 OSAS 19.4 136 41
12 MALE 48 182.4 57 HBP DLP 21.6 143 45
13 FEM 52 142.1 64 HBP DM2 OSAS 7 132.1 59
14 MALE 50 217 68 HBP DM2 OSAS 26.7 159 50
15 FEM 59 130 51 HBP OSAS 8.3 119.2 50
16 FEM 43 175 58 HBP OSAS 14 150.6 50
17 FEM 56 158.6 72 HBP knee arthrosis 24.5 119.7 55
18 MALE 21 234 68 - 22.5 181.4 53
19 FEM 51 149 64 HBP DM2 OSAS knee
arthrosis
16.6 123.4 53
20 FEM 27 173.6 83 DM2 DLP 19.3 140 67
Figure 1 - Weekly curve of weight loss during hospitalization (kg
x time in weeks).
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comparison tests (24,25). Figure 2 represents the results of
this analysis in the form of a curve that shows the relative
effect of treatment, which reflects the statistical impact of
each of the consecutive weekly weight variations on the
final treatment result.
We found that the first 14 weeks of the intervention
constituted the period during which the weight loss was
statistically significant for the study sample. The average
rate of weight loss was 2.0 kg/week until week 14, at which
time the group had achieved an average weight loss of 15%.
Eighteen individuals experienced weight losses of 10% of
their initial weight by an average of 8 weeks of hospitaliza-
tion (Table 2).
After determining that the patients were ready to undergo
surgery and after completion of the preoperative prepara-
tion, the patients were submitted to open GBP. Only the
patient with congestive heart failure developed a major
complication, namely, decreasing oxygen saturation and
respiratory difficulty that required intubation, assisted
ventilation and monitoring in the intensive care unit.
Nevertheless, this patient progressed well and was dis-
charged on postoperative day 6. The mean hospital stay was
4.6 days (range 3 to 6 days).
& DISCUSSION
There have been comparatively few studies analyzing
postoperative morbidity and mortality in SO patients, as
well as investigation of morbidity predictors and complica-
tion prevention protocols in this distinct group of patients.
Despite the important information available regarding the
benefits of preoperative weight loss, the following questions
remain: which patients should be encouraged to lose weight
before surgery? Are the benefits of weight loss dependent
on the pre-operative BMI, patient demographics, or other
factors? How much weight should be lost? What is the best
clinical intervention to achieve the intended result and for
how long should the intervention be performed? (26).
Among the supporters of preoperative weight loss, there
is no consensus regarding what percentage of weight the
patient undergoing bariatric surgery should lose before
surgery.
These important issues need to be addressed. We do not
know the point at which the prolongation of hospitalization
and treatment and the consequent delay in surgical
treatment yield a cost-benefit ratio that is disadvantageous
to the patient.
Male gender, hypertension, known risk factors for a PE
(prior PE, presence of a vena cava filter, hypoventilation and
pulmonary hypertension), age over 40 years, time of morbid
obesity, coronary disease, lung disease, dyslipidemia and
BMI $50 kg/m2 have been identified as risks associated
with bariatric surgery. SO is an independent risk factor for
intra- and postoperative complications (18-20). BMI is the
only risk factor that can be modified by preoperative weight
loss.
In this series, a 10% weight loss was achieved in 7.7 weeks
(Table 2), 15.2% in 15 weeks and 19.7% in 21.3 weeks of
hospitalization. Until week 14 (63% of the average length of
stay), 78.3% of patients achieved the intended weight loss.
At this point, the weight loss became statistically insignif-
icant.
Most surgical morbidity and mortality derived from SO
are associated with the greater technical difficulty of the
surgery, the presence and severity of comorbid conditions
directly related to the degree of obesity, disease duration,
limited mobility and decreased reserve to react and recover
from postoperative complications.
Figure 2 - Curve of relative effects of treatment. The impact of each of the consecutive weekly weight variations on the final treatment
result is shown. The abscissae axis shows the time of treatment in weeks and the ordinate axis shows statistical significance of the
weight variation. After the 14th week, the weekly weight variation lost statistical significance.
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Technically, surgeries in the SO are more difficult, mainly
due to steatohepatitis, hepatomegaly, the size and weight of
the greater omentum, the thickness and shortening of the
mesentery, the thickness of the lesser omentum and the
increased intra-abdominal pressure. Wound infection,
dehiscence and incisional hernias are highly prevalent in
open bariatric surgery and are significantly reduced by the
minimally invasive method of laparoscopic surgery. In
contrast, in laparoscopic surgery, the thicker abdominal
wall generates the need for greater torque to mobilize the
laparoscopic instruments, consequently lowering the sensi-
tivity and precision of movements.
The advantage of weight loss before surgery is evident by
the decrease in the operative time required (27). Alvarado
et al. retrospectively assessed 90 patients with an average
BMI of 48 kg/m2 and a mean preoperative weight loss of
7.25% of initial body weight and they noted significant
differences in the surgical time (i.e., a 36-minute reduction
in operative time in patients with losses of $5% of their
initial weight). A relationship was also observed between
the initial weight loss and the one-year surgical result;
specifically, every preoperative loss of 1% of the initial
weight led to a more than 1.8% loss of excess weight 1 year
after surgery (28).
In a prospective randomized study, Alami et al. also
demonstrated this relationship between weight and opera-
tive time; specifically, losses of .5% of the initial body
weight were associated with a 37-minute decrease in
operative time (29).
In association with technical facilitation, preoperative
weight loss also improves the control of related diseases,
with a reduction of the risks of anesthesia and surgery.
Weight loss of 10% has been shown to lead to positive
effects on comorbidities (30). Low-calorie diets are extre-
mely effective in acute weight loss. Two weeks of a low-
calorie liquid diet causes a significant decrease in liver
volume and changes in body composition, with decreased
fat mass (31). The loss of liver volume occurred mainly at
the beginning of the diet period, during the time of
consumption of liver glycogen and 80% of this decrease
occurred within 2 weeks of treatment initiation. The loss of
visceral fat occurred evenly over the period studied (32,33).
After 12 weeks of a very low caloric diet (456-680 cal/day
in 37 patients with an average BMI of 47 kg/m2), Colles et al.
demonstrated a mean loss of 10% of the initial weight of
patients and an average BMI decrease of 5 points (31).
Interestingly, in our series, the same weight loss was
obtained in an average of 7.7 weeks, i.e., in 36% less time.
The fact that almost all of our patients were SO may explain
this difference, as the rate of weight loss appears to be
greater in individuals with higher BMIs.
Despite the lack of an objective evaluation of this factor,
there was consensus in the perception by surgeons in our
group that weight loss greatly facilitated the implementa-
tion of the procedures, especially the mobilization of the
small bowel. When we retrospectively compared the
incidence of complications in this series with SO patients
operated upon the past 5 years, there were significant
differences in the incidences of complications and mortality
rates.
By retrospectively analyzing major complications (fistula,
cavitary abscess, bleeding and deep wound infection) and
mortality in the group of patients (n = 538) operated on
before the beginning of this protocol (17) and by stratifying
this group by BMI, we noted that the BMI.50 kg/m2 group
had a greater incidence of all major complications and
represented the patient group with the majority of compli-
cations in our series. The fistula rate was 2.19% for all the
patients (non-SO and SO), and the subgroup analysis
revealed a 1% fistula rate in the non-SO group (n= 345),
representing 30.76% of the total number of fistulas. The SO
group (n= 193) had a 4.66% fistula rate, representing 69.24%
of all fistulas (Table 3). Similar findings were obtained when
we analyzed all the other major complications, as shown in
Table 3. In this series of 20 subjects, we observed no
complications, highlighting a tendency toward a positive
effect of this intervention.
Table 2 - Length of stay necessary to achieve an approximately 10% loss of initial body weight.
Patient
Initial body weight
(IniBW) (kg) Weight 90% IniBW
Weight near 90%IniBW (kg)
achieved during the treatment
Weeks of treatment required to achieve a
weight near 90% IniBW
1 136 122.4 122.8 6
2 207 186.3 186.1 6
3 186.3 167.7 168.8 7
4 269 242.1 242.7 6
5 191 171.9 171 10
6 208.7 187.8 187 10
7 152.2 137 136.4 5
8 130 117 117.8 8
9 170 153 152 4
10 220 198 200.2 10
11 168.8 151.9 152 7
12 182.4 164.2 165 6
13 142.1 127.9 132.1(93%Pi) 8 (*)
14 217 195.3 194.6 4
15 130 117 119.2 (91.7%Pi) 17 (*)
16 175 157.5 156.6 11
17 158.6 142.7 142 11
18 234 210.6 211 6
19 149 134.1 133.8 14
20 173.6 156.2 156.8 9
Average length of stay required to achieve a weight near 90% of the initial body weight (*) 7.7
(*) Average length of stay, excluding patients 13 and 15, who did not reach at least a 10% loss of initial body weight.
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In bariatric surgery, any policy designed to decrease
operative morbidity is associated with reduced cost, as the
cost of complications, reoperations and prolonged stays in
intensive care greatly exceeds the cost of prevention
strategies (34). Thus, the option of preoperative hospitaliza-
tion for a relatively long period, at a low-cost institution,
such as the secondary health-care center where this study
was conducted, is justified by the very significant decrease
in morbidity and absence of mortality in a group of patients
with very high operative risk.
From the data obtained, we conclude that hospitalization
for diet control and weight loss prior to bariatric surgery is
safe and effective, occurring in a predictable manner in the
SO population and yielding significant weight loss until the
14th week of caloric restriction. After 14 weeks of treatment,
the weight loss stabilizes and loses significance, at which
time the patients in our series were submitted to surgery.
The main objective was to define the best time for these
patients to undergo surgery after the preoperative weight
loss. After the evaluation of these initial 20 patients, the SO
undergoing preoperative weight loss continued the treat-
ment, preferably for up to 14 weeks. The initial 20 patients
stayed longer because the optimal weight loss period was
unknown and the decision-making regarding when to
operate on the high-risk patients was made on a case by
case basis.
The goal of hospitalization is not to lose the highest
amount of preoperative weight possible, but rather to lose
the amount of weight that is closest to what is considered in
the literature as sufficient to reduce risk (between 10 and
20% of the initial weight). This goal was achieved in an
average of 14 weeks, which is the standard weight loss
period at our institution. SO patients are hospitalized either
until a 20% loss of initial weight is achieved or for 14 weeks,
whichever comes first, because we have demonstrated that
weight loss is insignificant after this period.
In this study, we also demonstrated that preoperative
weight loss through a controlled, very-low-energy diet, even
in the absence of drug treatment or increased physical
activity, is efficient in SO patients. The absence of major
surgical and postoperative complications in a group of
patients with increased preoperative risk is also indicative
of the benefits of the preoperative weight loss protocol in
the high-risk, SO population.
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